Clear Street’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Clear Street’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Buy	+99	New	+$1	﹤0.01%	1447
2026 Q1	–	Sell	-100	Closed	-$2	–	1154
2025 Q4	$2	Buy	+100	New	+$3	﹤0.01%	925
2025 Q2	–	Sell	-100	Closed	-$5	–	708
2025 Q1	$5	Buy	+100	New	+$7	﹤0.01%	567
2024 Q4	–	Sell	-100	Closed	-$7	–	619
2024 Q3	$7	Buy	+100	New	+$8	﹤0.01%	699
2023 Q4	–	Sell	-100	Closed	-$17	–	920
2023 Q3	$17	Sell	100 -279,940	-100%	-$44.1K	﹤0.01%	1065
2023 Q2	$53.2K	Buy	280,040 +100	+0%	+$18	﹤0.01%	425
2023 Q1	$45.7K	Buy	+279,940	New	+$54K	﹤0.01%	257

Other funds holding RCKTW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Clear Street's RCKTW Position: Q2 2026 in Review

Clear Street opened a new position in Rocket Pharmaceuticals Warrant (RCKTW) in Q2 2026: 99 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1447 among its holdings. This is a return to the name: Clear Street previously reported a position in RCKTW as recently as Q4 2025.

Clear Street first reported a position in RCKTW in Q1 2023 and has held it in 7 quarters since. The position peaked at $53.2K in Q2 2023. 11 funds tracked by Wall St. Rank hold RCKTW as of Q2 2026.

Clear Street held 99 shares of Rocket Pharmaceuticals Warrant worth $0 as of Q2 2026.
Rocket Pharmaceuticals Warrant was a new Clear Street position in Q2 2026.
Rocket Pharmaceuticals Warrant made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1447 holding.
Clear Street first reported a position in Rocket Pharmaceuticals Warrant in Q1 2023 and has held it in 7 quarters since.
Clear Street's Rocket Pharmaceuticals Warrant position peaked at $53.2K in Q2 2023.
11 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.